SCHEMBL30965344

SCHEMBL30965344

Cc1ccc(C)c(C2C(=O)Nc3ccc(Cl)cc32)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.41
PBRM1 Q86U86 1/20 0.40
POLB P06746 1/20 0.39
CYP1A2 P05177 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 3/20 0.38
TP53 P04637 3/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
CASP1 P29466 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
SLC8B1 Q6J4K2 1/20 0.38
CDYL2 Q8N8U2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29242350 1.00 PGR (0.41) PGRPBRM1POLBCYP1A2ALDH1A1
SCHEMBL29242288 0.89 PBRM1 (0.43) PGRPBRM1POLBCYP1A2ALDH1A1
SCHEMBL29242289 0.83 TP53 (0.49) POLBCYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL30965337 0.83 TP53 (0.49) POLBCYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL30965341 0.82 BRD4 (0.43) PGRPOLBCYP1A2ALDH1A1NPC1
SCHEMBL29242301 0.82 BRD4 (0.43) PGRPOLBCYP1A2ALDH1A1NPC1
SCHEMBL30965348 0.80 PGR (0.41) PGRPOLBCYP1A2KMT2AMAPT
SCHEMBL29242310 0.80 PGR (0.41) PGRPOLBCYP1A2KMT2AMAPT
SCHEMBL5678203 0.78 MAPT (0.44) PGRPBRM1CYP1A2ALDH1A1KDM4E
SCHEMBL30965343 0.77 BRD4 (0.41) PBRM1POLBCYP1A2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221565-A 3-Aryl indol-2-one compound with anticancer activity and application thereof in preparation of medicines for treating cancers 常州大学 2024-06-21 CN disclosed